Skip to main content
MLAB
NASDAQ Life Sciences

Mesa Labs Q1 Revenue Edges Up 1%, Adjusted Operating Income Jumps 19.5%

Tom Rudovsky · Reported by Reuters
More coverage: Scientific Instrument Stocks · Technology
Sentiment info
Neutral
Importance info
7
Price
$101.62
Mkt Cap
$568.652M
52W Low
$58.834
52W High
$113.99
52W Position info
73% above low
Off High info
11% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

MLAB sits 73% above its 52-week low of $58.834.

Summary

Mesa Labs reported fiscal Q1 revenue of approximately $62.8 million, a 1% year-over-year increase, driven by its Calibration Solutions and Biopharmaceutical Development divisions. Adjusted operating income excluding unusual items rose 19.5%, reflecting improved gross margins in three of four divisions from favorable product mix and supply chain efficiencies. However, net income fell 40.3% due to higher nonoperating expenses, and the Sterilization and Disinfection Control unit saw a revenue decline tied to fulfillment challenges. The company plans to provide full-year guidance in November alongside first-half results, leaving near-term visibility limited. This follows a strong fiscal 2026 turnaround reported in May, and the mixed Q1 performance suggests uneven recovery across segments.

At the time of this announcement, MLAB was trading at $101.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $568.7M. The 52-week trading range was $58.83 to $113.99. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

MLAB - Latest Insights

MLAB
Nov 09, 2026, 4:40 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $122.00
Real-time Price: $135.81 info
Change: +$13.81 (+11%) info
Market Cap: $763.323M info
MLAB
Nov 09, 2026, 4:35 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $122.00
Real-time Price: $135.81 info
Change: +$13.81 (+11%) info
Market Cap: $763.323M info
MLAB
Nov 09, 2026, 4:16 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $122.00
Real-time Price: $135.81 info
Change: +$13.81 (+11%) info
Market Cap: $763.323M info
MLAB
Oct 13, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $128.07
Real-time Price: $135.81 info
Change: +$7.74 (+6%) info
Market Cap: $763.323M info
MLAB
Oct 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $128.07
Real-time Price: $135.81 info
Change: +$7.74 (+6%) info
Market Cap: $763.323M info